|
|
|
Market Research Report
The U.S. Market for Prescription Ophthalmic Drugs, Devices, Diagnostics,and Surgical Equipment
| Published by |
BCC Research |
| Published |
September, 2006 |
Product code |
46202 |
| Content info |
144 pages 42 tables |
| Price |
|
|
The U.S. Market for Prescription Ophthalmic Drugs, Devices, Diagnostics,and Surgical Equipment published by BCC Research in September, 2006. This report consists of 144 pages 42 tables and the price starts from US $ 4850.
Abstract
INTRODUCTION
The aging of the population in the United States will result in a two-fold
increase in the 65 and over population by 2030, a population that accounts for
the highest incidence and prevalence of eye conditions and diseases. This sets
the stage for increased research and development activities, speedy market
approvals, and higher awareness through education. Additionally, current
market competitors will endure pressure from the industry to continually
provide advances in therapies and equipment and to compete with emerging
competitors, who focus significantly on unmet needs of the ophthalmic
consumer, including treatments for back of the eye conditions. The industry is
likely to experience a burst of new products and heavy competition as the U.S.
ophthalmic market advances.
SCOPE OF STUDY
This report contains:
- A thorough evaluation of the U.S. prescription ophthalmic pharmaceutical,
device, diagnostic, and surgical market, with forecasts to 2011
- Market analysis focused on specific diseases and conditions such as
cataract, glaucoma and refractive treatments
- Information regarding incidence and prevalence of eye conditions and risk
factors associated with those conditions
- Examination of research and development activities with an emphasis on
segments offering benefits to aging populations
- Profiles of the major companies in the industry as well as a detailed
patent analysis.
METHODOLOGY
The information for this BCC report was obtained through primary and secondary
data collection methods. Primary methods included interviews with key
executives, product managers, and clinical specialists involved in the
ophthalmic drug industry. Secondary methods included published literature in
the area of ophthalmic drugs, investment reports, company literature, and
various medical and business journals.
All market data pertains the U.S. market at the manufacturers' level. Data is
expressed in current U.S. dollars. The base year of the report is 2006, with
historical data provided for 2004 and 2005 and forecast data provided for
2011. Historical, base year, and forecast data is provided for each market
segment of the report. Competitor market shares are provided for each market
segment for the 2006 base year.
Table of Contents
- INTRODUCTION
- STUDY GOALS AND OBJECTIVES
- REASONS FOR DOING THE STUDY
- SCOPE AND FORMAT
- ANALYST CREDENTIALS
- DISCLAIMER
- SUMMARY
- Summary Table:
- U.S. OPHTHALMIC MARKET FORECAST BY SEGMENT, THROUGH 2011 ($ MILLION)
- Summary Figure:
- U.S. OPHTHALMIC MARKET ANALYSIS BY SEGMENT, 2004-2011 ($ MILLION)
- INDUSTRY OVERVIEW
- VISION
- STRUCTURE OF THE EYE
- PATHOLOGY
- POPULATION GROWTH AND DEMOGRAPHICS
- Table 1 U.S. INCIDENCE AND PREVALENCE OF SELECTED EYE CONDITIONS AND
DISEASES
- Figure 1 U.S. INCIDENCE AND PREVALENCE OF SELECTED EYE CONDITIONS AND
DISEASES
- OPHTHALMIC CONDITIONS AND DISEASES
- DIABETIC RETINOPATHY
- AGE-RELATED MACULAR DEGENERATION
- OCULAR ALLERGIES
- HERPES SIMPLEX VIRUS KERATITIS
- CYTOMEGALOVIRUS RETINITIS
- CATARACTS
- GLAUCOMA
- Table 2 GLAUCOMA TYPES AND KEY POINTS
- Table 3 KNOWN CAUSES OF UVEITIS
- TRACHOMA
- RETINAL DETACHMENT
- DRY EYE SYNDROME
- STRABISMUS
- Table 4 STRABISMUS TYPES AND RELATED CATEGORIES
- OCULAR MUSCLE SPASMS
- ISSUES AFFECTING THE MARKET
- LITIGATION
- The FDA' s Precautions Involving LASIK Eye Surgery
- OPHTHALMIC PHARMACEUTICAL AND DEVICE COUNTERFEITING
- OPHTHALMIC PHARMACEUTICAL/DEVICE RECALLS AND LABEL UPDATES
- Table 5 PRODUCTS WITH OCULAR RECALLS 2003-2006
- Table 6 GOVERNMENT BILLS/LAWS RELATED TO CONTACT LENSES AND THEIR
MANUFACTURERS
- S. 2480: CONTACT LENS CONSUMER PROTECTION ACT
- S. 172
- FAIRNESS TO CONTACT LENS CONSUMERS ACT
- ADVERTISING
- Table 7 SELECTED LEADING OPHTHALMIC MANUFACTURERS/PROVIDERS IN UNITED
STATES FOR 2005 ($)
- PHARMACEUTICAL SIDE EFFECTS AND OPHTHALMIC CONDITIONS
- Table 8 DRUG COMBINATIONS AND REPORTED SIDE EFFECTS, 2003-2006
- PRODUCT MARKETS
- PRESCRIPTION OPHTHALMIC PHARMACEUTICALS
- Table 9 PRODUCT SUMMARY OF OPHTHALMIC ANTI-INFLAMMATORY DRUGS BY
MANUFACTURER AND FDA APPROVAL DATE
- Research and Development
- Anti-Infectives
- Table 10 PRODUCT SUMMARY OF ANTI-INFECTIVES BY MANUFACTURER AND FDA
APPROVAL DATE
- Table 11 PRODUCTS IN DEVELOPMENT FOR ANTI-INFECTIVES, BY MANUFACTURER
AND DEVELOPMENT PHASE, 2006
- Antihistamines and Mast Cell Stabilizers
- Table 12 PRODUCT SUMMARY OF SELECTED ANTIHISTAMINES AND MAST CELL
STABLIZIERS BY MANUFACTURER AND FDA APPROVAL DATE
- Beta- Adrenergic Blockers
- Table 13 PRODUCT SUMMARY OF BETA BLOCKERS BY MANUFACTURER AND FDA
APPROVAL DATE
- Table 14 BETA BLOCKERS IN DEVELOPMENT BY MANUFACTURER AND DEVELOPMENT
PHASE
- Table 15 PRODUCT SUMMARY OF PROSTAGLANDINS BY MANUFACTURER AND FDA
APPROVAL DATE
- Table 16 PROSTAGLANDINS IN DEVELOPMENT BY MANUFACTURER AND DEVELOPMENT
PHASE
- Other Pharmaceutical Treatments
- Carbonic Anhydrase Inhibitors
- Dry Eye Treatments
- Miotics
- Mydriatics and Cycloplegics
- Ocular Anesthetics
- Ocular Muscle Spasm Treatments
- Pain Management Treatments
- Vasoconstrictors
- Other Treatments
- Table 17 PRODUCT SUMMARY OF OTHER PHARMACEUTICAL TREATMENTS BY
MANUFACTURER, PRODUCT TYPE, AND FDA APPROVAL DATE
- Table 18 OTHER PHARMACEUTICAL PRODUCTS IN DEVELOPMENT FOR OPHTHALMIC
CONDITIONS, BY MANUFACTURER AND DEVELOPMENT PHASE
- Table 19 U.S. MARKET FORECAST FOR OPHTHALMIC PHARMACEUTICALS BY PRODUCT
TYPE, THROUGH 2011 ($ MILLION)
- Figure 2 U.S. MARKET FOR OPHTHALMIC PHARMACEUTICALS BY PRODUCT TYPE,
2004-2011 ($ MILLION)
- Table 20 DISTRIBUTION OF REVENUES FOR OPHTHALMIC PHARMACEUTICALS BY
CONDITION, 2006 (PERCENT/ $ MILLION)
- Figure 3 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC PHARMACEUTICALS BY
CONDITION, 2006 (%)
- Table 21 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC PHARMACEUTICALS BY
MANUFACTURER REVENUES, 2006 ($ MILLION)
- Figure 4 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC PHARMACEUTICALS BY
MANUFACTURERS REVENUES, 2006 (%)
- OPHTHALMIC DIAGNOSTICS
- PRODUCT DESCRIPTIONS
- Visual Acuity Test
- Dilated Eye Exam
- Manifest Refraction
- Pupil Reflex
- Tonometry Test
- Ophthalmoscopy
- Gonioscopy
- Slit Lamp Examinations
- Fluorescein Staining
- Eye Muscle Tests
- Corneal Thickness
- Pachymetry
- Echography
- Imaging Diagnostics
- Optic Nerve Imaging
- Optic Nerve Computer Imaging
- Aberrometer
- Innovative Imaging, Inc. and Echography
- Corneal Topography
- Flourescein Angiography
- Slit-Lamp Photography
- Table 22 SELECT CONDITIONS FOUND THROUGH SLIT-LAMP PHOTOGRAPHY
- Specular Microscopy
- Glaucoma-Scope
- Fundus Cameras
- Table 23 U.S. MARKET FORECAST FOR OPHTHALMIC DIAGNOSTICS BY PRODUCT
TYPE, THROUGH 2011 ($ MILLION)
- Figure 5 U.S. MARKET FOR OPHTHALMIC DIAGNOSTICS BY PRODUCT TYPE,
2004-2011 ($ MILLION)
- Table 24 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC DIAGNOSTICS BY
CONDITION, 2006 (%)
- Figure 6 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC DIAGNOSTICS BY
CONDITION, 2006 (%)
- COMPETITIVE STRUCTURE AND MARKET SHARE
- Table 25 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS BY
MANUFACTURERS REVENUES, 2006 (%/$ MILLION)
- Figure 7 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS BY
MANUFACTURERS REVENUES, 2006 (%)
- VISION CORRECTION AND VISION PRESERVATION DEVICES
- PRODUCT DESCRIPTIONS
- Soft (Disposable) Lenses
- Gas Permeable Lenses
- Cosmetic Lenses
- Shaping Lenses
- MARKET SIZE AND GROWTH
- Table 26 U.S. MARKET FORECAST FOR CONTACT LENSES BY TYPE, THROUGH 2011
($ MILLION)
- Figure 8 U.S. MARKET FOR CONTACT LENSES BY TYPE, 2004-2011 ($ MILLION)
- COMPETITIVE STRUCTURE AND MARKET SHARE
- Table 27 U.S. COMPETITIVE MARKET SHARE FOR CONTACT LENSES BY
MANUFACTURERS REVENUES, 2006 (PERCENT/ $ MILLION)
- Figure 9 COMPETITIVE U.S. MARKET SHARE FOR CONTACT LENSES BY
MANUFACTURERS REVENUES, 2006 (%)
- SURGICAL EQUIPMENT
- PRODUCT DESCRIPTIONS
- Corneal Procedures
- Intracorneal Rings
- Cornea Transplants (Penetrating keratoplasty)
- Deep Anterior Lamellar Corneal Transplant (DLEK)
- DSEK (Descemet' s Stripping with Endothelial Keratoplasty)
- Lens Procedures
- Verisyse Lens Implant
- Lens Replacements
- Refractive Procedures
- Mechanical Microkeratome
- Blade-Free Microkeratome
- Lasek, LASIK, and PRK
- Retinal Procedures
- Surgical Procedures for Cataracts
- Phacoemulsification Cataract Surgery
- Endocapsular Tension Ring
- Table 28 ENDOSCAPULAR TENSION RINGS AVAILABLE BY MANUFACTURER
- Surgical Procedures for Glaucoma
- Glaucoma Implant
- Neodymium: YAG Laser Cyclophotocoagulation (YAG CP)
- Diode Laser Transscleral Cyclophotocoagulation (Diode CYC)
- Selective Laser Trabeculoplasty (SLT)
- Argon Laser Trabeculoplasty (ALT)
- Laser Peripheral Iridotomy (LPI)
- Filtering Microsurgery
- Procedures for Age-Related Macular Degeneration (AMD)
- Focal Laser Treatment and PDT
- Ophthalmic Lasers
- Blade-Free Femtosecond Microkeratome
- Table 29 MICROKERATOME/ FEMTOSECOND SYSTEMS BY MANUFACTURER
- Table 30 EXCIMER LASER SYSTEMS BY MANUFACTURER
- Table 31 SELECT YAG LASER SYSTEMS BY MANUFACTURER
- Other Laser Systems
- Intraocular Lenses and Other Lens Implants
- Shunts and Other Drainage Devices
- RESEARCH AND DEVELOPMENT
- MARKET SIZE AND GROWTH
- Table 32 U.S. MARKET FORECAST FOR OPHTHALMIC SURGICAL EQUIPMENT BY
PRODUCT TYPE, THROUGH 2011 ($ MILLION)
- Figure 10 U.S. MARKET FOR SURGICAL EQUIPMENT BY PRODUCT TYPE, 2004-2011
($ MILLION)
- Table 33 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC SURGICAL EQUIPMENT
BY CONDITION, 2006 (%)
- Figure 11 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC SURGICAL
EQUIPMENT BY CONDITION, 2006 (%)
- COMPETITIVE STRUCTURE AND MARKET SHARE
- Table 34 COMPETITIVE U.S. MARKET SHARE FOR SURGICAL EQUIPMENT BY
MANUFACTURERS REVENUES, 2006 (PERCENT/$ MILLION)
- Figure 12 COMPETITIVE U.S. MARKET SHARE FOR SURGICAL EQUIPMENT BY
MANUFACTURERS REVENUES, 2006 (%)
- Table 35 TOTAL U.S. OPHTHALMIC MARKET FORECAST, THROUGH 2011 ($ MILLION)
- Figure 13 TOTAL U.S. OPHTHALMIC MARKET FORECAST, 2004-2006, AND 2011 ($
MILLION)
- TOTAL MARKET PERCENTAGE DISTRIBUTION BY MARKET SEGMENT
- Table 36 TOTAL U.S. OPHTHALMIC MARKET FORECAST BY SEGMENT, THROUGH 2011
($ MILLION)
- Figure 14 U.S. MARKET SUMMARY TOTAL OPHTHALMIC MARKET, 2004-2011 ($
MILLION)
- Figure 15 U.S. MARKET SUMMARY TOTAL OPHTHALMIC MARKET, 2004-2011 (%)
- INDUSTRY PARTICIPANTS BY PRODUCT
- Table 37 U.S. MARKET SUMMARY MARKET LEADERS BY PRODUCT TYPE
- Table 38 U.S. COMPETITIVE ANALYSIS FOR THE U.S. OPHTHALMIC MARKET BY TOP
PROVIDERS AND REVENUES, 2006 (PERCENT/$ MILLION)
- TECHNOLOGY
- CURRENT USES OF TECHNOLOGY
- ADVANCED MEDICAL OPTIC' S WAVESCAN/ CUSTOMVUE TECHNOLOGY
- CRYSTALENS BY EYEONICS, INC.
- HYBRID LENSES BY SYNERGEYES, INC.
- SILICONE HYDROGEL
- Table 39 EXTENDED WEAR GAS PERMEABLE SOFT LENSES BY MANUFACTURER
- VISTAKON' S SENOFILCON A LENS
- VISTAKON' S HIGHLY PERMEABLE LENS TECHNOLOGY
- IMPLANTABLE CONTACT LENSES (PHAKIC IOL)
- RETISERT IMPLANT BY BAUSCH & LOMB
- ORTHOKERATOLOGY
- NIKE MAXSIGHT
- TORSIONAL PHACOEMULSIFICATION
- PATENT EVALUATION BY DRUG
- Table 40 U.S. DRUG PATENTS FOR OPHTHALMIC CONDITIONS
- Table 41 NUMBER OF U.S. PATENT EXPIRATIONS BY YEAR FOR OPHTHALMIC DRUGS,
2006-2019
- PATENT EVALUATION BY TECHNOLOGY
- Table 42 U.S. OPHTHALMIC PATENT EVALUATION BY MAJOR TECHNOLOGY
- NEW TECHNOLOGY DEVELOPMENT
- COMPANY PROFILES
- ADVANCED MEDICAL OPTICS, INC.
- ALCON LABORATORIES, INC.
- ALLERGAN, INC.
- BAUSCH & LOMB INC.
- CARL ZEISS AG
- CIBA VISION
- COOPERVISION, INC.
- MERCK & CO., INC.
- NEW WORLD MEDICAL, INC.
- NIDEK CO., LTD.
- NOVARTIS INTERNATIONAL, AG
- PFIZER, INC.
- STAAR SURGICAL CO.
- VISTAKON
- APPENDIX: OPHTHALMIC PRODUCT MANUFACTURERS
- LIST OF OPHTHALMIC PRODUCT MANUFACTURERS
- LIST OF TABLES
- Summary Table:
- U.S. OPHTHALMIC MARKET FORECAST BY SEGMENT, THROUGH 2011 ($ MILLION)
- Table 1 U.S. INCIDENCE AND PREVALENCE OF SELECTED EYE CONDITIONS AND
DISEASES
- Table 2 GLAUCOMA TYPES AND KEY POINTS
- Table 3 KNOWN CAUSES OF UVEITIS
- Table 4 STRABISMUS TYPES AND RELATED CATEGORIES
- Table 5 PRODUCTS WITH OCULAR RECALLS 2003-2006
- Table 6 GOVERNMENT BILLS/LAWS RELATED TO CONTACT LENSES AND THEIR
MANUFACTURERS
- Table 7 SELECTED LEADING OPHTHALMIC MANUFACTURERS/PROVIDERS IN UNITED
STATES FOR 2005 ($)
- Table 8 DRUG COMBINATIONS AND REPORTED SIDE EFFECTS, 2003-2006
- Table 9 PRODUCT SUMMARY OF OPHTHALMIC ANTI-INFLAMMATORY DRUGS BY
MANUFACTURER AND FDA APPROVAL DATE
- Table 10 PRODUCT SUMMARY OF ANTI-INFECTIVES BY MANUFACTURER AND FDA
APPROVAL DATE
- Table 11 PRODUCTS IN DEVELOPMENT FOR ANTI-INFECTIVES, BY MANUFACTURER
AND DEVELOPMENT PHASE, 2006
- Table 12 PRODUCT SUMMARY OF SELECTED ANTIHISTAMINES AND MAST CELL
STABLIZIERS BY MANUFACTURER AND FDA APPROVAL DATE
- Table 13 PRODUCT SUMMARY OF BETA BLOCKERS BY MANUFACTURER AND FDA
APPROVAL DATE
- Table 14 BETA BLOCKERS IN DEVELOPMENT BY MANUFACTURER AND DEVELOPMENT
PHASE
- Table 15 PRODUCT SUMMARY OF PROSTAGLANDINS BY MANUFACTURER AND FDA
APPROVAL DATE
- Table 16 PROSTAGLANDINS IN DEVELOPMENT BY MANUFACTURER AND DEVELOPMENT
PHASE
- Table 17 PRODUCT SUMMARY OF OTHER PHARMACEUTICAL TREATMENTS BY
MANUFACTURER, PRODUCT TYPE, AND FDA APPROVAL DATE
- Table 18 OTHER PHARMACEUTICAL PRODUCTS IN DEVELOPMENT FOR OPHTHALMIC
CONDITIONS, BY MANUFACTURER AND DEVELOPMENT PHASE
- Table 19 U.S. MARKET FORECAST FOR OPHTHALMIC PHARMACEUTICALS BY PRODUCT
TYPE, THROUGH 2011 ($ MILLION)
- Table 20 DISTRIBUTION OF REVENUES FOR OPHTHALMIC PHARMACEUTICALS BY
CONDITION, 2006 (PERCENT/$ MILLION)
- Table 21 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC PHARMACEUTICALS BY
MANUFACTURER REVENUES, 2006 ($ MILLION)
- Table 22 SELECT CONDITIONS FOUND THROUGH SLIT-LAMP PHOTOGRAPHY
- Table 23 U.S. MARKET FORECAST FOR OPHTHALMIC DIAGNOSTICS BY PRODUCT
TYPE, THROUGH 2011 ($ MILLION)
- Table 24 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC DIAGNOSTICS BY
CONDITION, 2006 (%)
- Table 25 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS BY
MANUFACTURERS REVENUES, 2006 (%/$ MILLION)
- Table 26 U.S. MARKET FORECAST FOR CONTACT LENSES BY TYPE, THROUGH 2011
($ MILLION)
- Table 27 U.S. COMPETITIVE MARKET SHARE FOR CONTACT LENSES BY
MANUFACTURERS REVENUES, 2006 (PERCENT/$ MILLION)
- Table 28 ENDOSCAPULAR TENSION RINGS AVAILABLE BY MANUFACTURER
- Table 29 MICROKERATOME/FEMTOSECOND SYSTEMS BY MANUFACTURER
- Table 30 EXCIMER LASER SYSTEMS BY MANUFACTURER
- Table 31 SELECT YAG LASER SYSTEMS BY MANUFACTURER
- Table 32 U.S. MARKET FORECAST FOR OPHTHALMIC SURGICAL EQUIPMENT BY
PRODUCT TYPE, THROUGH 2011 ($ MILLION)
- Table 33 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC SURGICAL EQUIPMENT
BY CONDITION, 2006 (%)
- Table 34 COMPETITIVE U.S. MARKET SHARE FOR SURGICAL EQUIPMENT BY
MANUFACTURERS REVENUES, 2006 (PERCENT/$ MILLION)
- Table 35 TOTAL U.S. OPHTHALMIC MARKET FORECAST, THROUGH 2011 ($ MILLION)
- Table 36 TOTAL U.S. OPHTHALMIC MARKET FORECAST BY SEGMENT, THROUGH 2011
($ MILLION)
- Table 37 U.S. MARKET SUMMARY MARKET LEADERS BY PRODUCT TYPE
- Table 38 U.S. COMPETITIVE ANALYSIS FOR THE U.S. OPHTHALMIC MARKET BY TOP
PROVIDERS AND REVENUES, 2006 (PERCENT/$ MILLION)
- Table 39 EXTENDED WEAR GAS PERMEABLE SOFT LENSES BY MANUFACTURER
- Table 40 U.S. DRUG PATENTS FOR OPHTHALMIC CONDITIONS
- Table 41 NUMBER OF U.S. PATENT EXPIRATIONS BY YEAR FOR OPHTHALMIC DRUGS,
2006-2019
- Table 42 U.S. OPHTHALMIC PATENT EVALUATION BY MAJOR TECHNOLOGY
- LIST OF FIGURES
- Summary Figure:
- U.S. OPHTHALMIC MARKET ANALYSIS BY SEGMENT, 2004-2011 ($ MILLION)
- Figure 1 U.S. INCIDENCE AND PREVALENCE OF SELECTED EYE CONDITIONS AND
DISEASES
- Figure 2 U.S. MARKET FOR OPHTHALMIC PHARMACEUTICALS BY PRODUCT TYPE,
2004-2011 ($ MILLION)
- Figure 3 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC PHARMACEUTICALS BY
CONDITION, 2006 (%)
- Figure 4 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC PHARMACEUTICALS BY
MANUFACTURERS REVENUES, 2006 (%)
- Figure 5 U.S. MARKET FOR OPHTHALMIC DIAGNOSTICS BY PRODUCT TYPE,
2004-2011 ($ MILLION)
- Figure 6 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC DIAGNOSTICS BY
CONDITION, 2006 (%)
- Figure 7 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS BY
MANUFACTURERS REVENUES, 2006 (%)
- Figure 8 U.S. MARKET FOR CONTACT LENSES BY TYPE, 2004-2011 ($ MILLION)
- Figure 9 COMPETITIVE U.S. MARKET SHARE FOR CONTACT LENSES BY
MANUFACTURERS REVENUES, 2006 (%)
- Figure 10 U.S. MARKET FOR SURGICAL EQUIPMENT BY PRODUCT TYPE, 2004-2011
($ MILLION)
- Figure 11 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC SURGICAL
EQUIPMENT BY CONDITION, 2006 (%)
- Figure 12 COMPETITIVE U.S. MARKET SHARE FOR SURGICAL EQUIPMENT BY
MANUFACTURERS REVENUES, 2006 (%)
- Figure 13 TOTAL U.S. OPHTHALMIC MARKET FORECAST, 2004-2006, AND 2011 ($
MILLION)
- Figure 14 U.S. MARKET SUMMARY TOTAL OPHTHALMIC MARKET, 2004-2011 ($
MILLION)
- Figure 15 U.S. MARKET SUMMARY TOTAL OPHTHALMIC MARKET, 2004-2011 (%)
|
 |
